Phase II study of adjuvant chemotherapy with S1 plus oxaliplatin for Chinese patients with gastric cancer

BACKGROUND: S-1 plus oxaliplatin(SOX) has been demonstrated to be effective and well tolerated for patients with metastatic gastric cancer. We conducted this phase II study to evaluate the feasibility of SOX as adjuvant chemotherapy for gastric cancer after curative resection. METHODS: Adjuvant chem...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Guoxiu, Zhao, Jiuda, Song, Yan, Zhang, Wen, Sun, Yongkun, Zhou, Aiping, Huang, Jing, Du, Feng, Yang, Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5944043/
https://www.ncbi.nlm.nih.gov/pubmed/29743043
http://dx.doi.org/10.1186/s12885-018-4480-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5944043/
https://www.ncbi.nlm.nih.gov/pubmed/29743043
http://dx.doi.org/10.1186/s12885-018-4480-9

Ejemplares similares